SILICON LABORATORIES INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($64.9m)
Net Income (Loss) Available to Common Stockholders, Basic $61.5m $47.1m $83.6m $19.3m $12.5m $91.4m ($34.5m) ($191.0m)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $47.1m $83.6m $19.3m $12.5m $91.4m ($34.5m)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $91.4m ($34.5m)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $0 $0
Depreciation $13.2m $14.8m $15.9m $16.9m $17.8m $22.5m $25.7m $25.6m $24.7m
Amortization of Debt Issuance Costs and Discounts $10.1m $12.9m $13.5m $21.4m $21.4m $2.0m $960k $0 $0
Amortization of Intangible Assets $27.3m $27.1m $38.0m $39.5m $44.7m $44.7m $34.1m $25.4m $23.0m $13.4m
Deferred Income Tax Expense (Benefit) ($4.1m) ($26.2m) ($8.5m) $23.0m ($6.5m) ($18.2m) ($10.9m) $29.5m $881k
Share-based Payment Arrangement, Noncash Expense $39.6m $44.8m $50.1m $54.8m $60.1m $60.5m $48.2m $61.5m $80.3m
Payment, Tax Withholding, Share-based Payment Arrangement $19.5m $16.3m $18.1m $15.4m $18.2m $16.4m $15.7m
Share-based Payment Arrangement, Expense $39.6m $44.8m $50.1m $54.8m $60.1m $60.5m $48.2m $61.5m $80.3m
Gain (Loss) on Extinguishment of Debt ($4.1m) ($3k) $0
Income (Loss) from Equity Method Investments $3.4m ($16.0m) $0 $0
Income Tax Expense (Benefit) $3.0m $29.8m ($11.4m) $30.4m $2.8m $38.5m $7.9m $36.2m $7.0m
Interest Expense Nonoperating $1.3m $975k
Operating Lease, Lease Income $6.2m $3.1m $2.8m $2.2m
Other Nonoperating Income (Expense) ($485k)
Changes in operating assets and liabilities:
Non-cash transactions:
Additional Financial Items
Increase (Decrease) in Accounts Receivable ($46k) ($3.2m) ($3.9m) $2.4m $17.6m ($26.9m) ($42.1m) $25.2m $10.0m
Increase (Decrease) in Inventories $6.1m $13.4m ($7.7m) ($2.2m) ($10.7m) $51.0m $93.4m ($88.5m) ($10.0m)
Increase (Decrease) in Accounts Payable $263k ($468k) $6.0m $7.8m $15.3m $36.8m ($25.6m) ($15.2m) $6.3m
Goodwill $276.1m $288.2m $397.3m $398.4m $631.9m $376.4m $376.4m $376.4m $376.4m
Investment Income, Interest $1.3m
Operating Expenses $355.2m $369.2m $436.2m $453.6m $489.2m $523.3m $484.7m $477.7m $527.5m
Operating Cash Flow $105.4m $189.5m $173.5m $166.5m $135.7m $71.8m ($30.3m) ($13.9m) $95.7m
Cash Flow From Continuing Operating Activities $105.4m $189.5m $173.5m $166.5m $135.7m $141.3m ($30.3m) ($13.9m) $95.7m
Net Cash Provided by (Used in) Operating Activities $105.4m $189.5m $173.5m $166.5m $135.7m $135.7m $91.2m ($30.3m) ($13.9m) $95.7m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $10.9m $12.3m $24.5m $16.3m $20.4m $20.4m $26.5m $22.3m $11.7m $29.9m
Property, plant and equipment acquisitions funded by liabilities $10.9m $12.3m $24.5m $16.3m $20.4m $26.5m $22.3m $11.7m $29.9m
Payments to Acquire Businesses, Net of Cash Acquired $6.5m $15.2m $239.7m $2.5m $316.8m
Net Cash Provided by (Used in) Investing Activities ($49.3m) ($374.3m) ($197.0m) ($106.8m) ($361.0m) ($361.0m) $240.5m $469.8m $113.1m ($12.0m)
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt $81.2m $845.0m $845.0m $0 $80.0m $0 $0
Repayments of Long-term Debt $5.0m $72.5m $624.7m $21k $571.2m $45.0m $0
Proceeds from Issuance of Common Stock $13.3m $11.8m $13.3m $14.5m $15.0m $15.0m $11.8m $14.6m $16.3m $14.6m
Payments for Repurchase of Common Stock $40.5m $39.3m $26.7m $16.3m $883.4m $217.1m $16k $0
Net Cash Provided by (Used in) Financing Activities ($83.8m) $313.0m ($48.8m) ($29.6m) $200.9m $200.9m ($887.1m) ($711.9m) ($45.1m) ($1.1m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($27.6m) $128.3m ($72.3m) $30.1m ($24.4m) ($24.4m) ($574.7m) ($272.4m) $54.1m $82.6m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $197.0m $227.1m $202.7m $499.9m $227.5m $281.6m $364.2m
Cash, Cash Equivalents, and Short-term Investments $288.5m $290.8m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $2.5m $3.9m $6.2m $6.4m $8.7m $8.7m $4.4m $4.5m $988k $634k
Income Taxes Paid, Net $11.2m $8.9m $20.6m $10.3m $7.2m $7.2m $132.0m $31.7m $19.1m $11.0m